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Abstract
Background: We aimed to clarify the factors affecting outcomes of home care for patients with malignant
diseases.
Methods: Of 607 patients who were treated in 10 clinics specialized in home care between January and
December 2007 at Chiba, Fukuoka, Iwate, Kagoshima, Tochigi and Tokyo prefectures across Japan, 346 (57%; 145
men and 201 women) had malignant diseases. We collected information on medical and social backgrounds,
details of home care, and its outcomes based on their medical records.
Results: Median age of the patients was 77 years (range, 11-102), and 335 patients were economically self-
sufficient. Their general condition was poor; advanced cancer (n = 308), performance status of 3-4 (n = 261), and
dementia (n = 121). At the beginning of home care, 143 patients and 174 family members expressed their wish to
die at home. All the patients received supportive treatments including fluid replacement and oxygenation. Median
duration of home care was 47 days (range, 0-2,712). 224 patients died at home. For the remaining 122, home care
was terminated due to complications (n = 109), change of attending physicians (n = 8), and others (n = 5). The
factors which inhibited the continuity of home care were the non-use of home-visit nursing care (hazard ratio [HR]
= 1.78, 95% confidence interval [CI]: 1.05-3.00, p = 0.03), the fact that the patients themselves do not wish to die at
home (HR = 1.83, CI: 1.09-3.07, p = 0.02), women (HR = 1.81, CI: 1.11-2.94, p = 0.02), and age (HR = 0.98, CI: 0.97-
1.00, p = 0.02).
Conclusions: Continuation of home care is influenced by patients’ age, gender, will, and use of home-visit nursing.
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Background
Most cancer patients prefer to die at home [1]. In
response to the wishes of such patients, home care for
terminally ill cancer patients has been developed since
the 1990s, and studies on this issue are still increasing
in number [2]. In home care, patients can be treated
while taking into consideration the set of values and life-
style habits of each individual.
Home care has provided a new treatment option for
cancer patients, while it remains unknown who are opti-
mal candidates for this treatment. Several researchers
reported that success of home care is influenced by
medical conditions, incomes, and education levels of
patients and their families [3-5]. These studies provided
us valuable information on home care; however, they
are small-sized studies with their backgrounds varied
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care have not yet been elucidated.
To investigate the factors that influence continuation
of home care for patients with malignant diseases, we
conducted a retrospective study involving 364 cancer
patients who were treated at home.
Methods
Data collection
This study was conducted with the participation of 10
clinics specialized in home care at Chiba, Fukuoka,
Iwate, Kagoshima, Tochigi and Tokyo prefectures across
Japan. Oncologists worked as full-time staffs in all the
clinics.
Patients who have been mainly affected by cancer
were selected from 607 patients who received home
care between January 1
st and December 31
st 2007. We
collected information on medical and social back-
grounds, details of home care, and its outcomes using
their medical records. The parts of information that
could not be assessed from medical records were inves-
tigated by asking the attending physicians. Performance
status (PS) was classified according to the criteria of the
Eastern Cooperative Oncology Group [6].
Endpoints and statistical analysis
This study aimed to elucidate the factors influencing
the continuation of home care for patients with malig-
nant diseases. Data were analyzed as of December 31
st
2007.
The cumulative incidences of death at home and hos-
pitals were evaluated using the Gray’s method [7]. Asso-
ciations between potential prognostic factors and
outcomes were evaluated using the Cox’s proportional
hazard regression models. Events were defined as dis-
continuation of home care due to causes other than
deaths at home. Data on patients who died at home
were censored. The following variables were considered:
patients’ age at the beginning of home care, gender, pre-
sence of dementia, presence of patients’ wish to die at
home at the beginning of home care, residence (patients’
own home or a facility), and the concomitant use of
home-visit nursing care. Variables that had a p value of
less than 0.25 on univariate analysis were entered into
the mixed-effects model. Those that contributed less
than 10 percent to the overall ability of the model were
sequentially eliminated. The level of significance was set
at p < 0.05.
For the implementation of this study, we have
obtained approval of the Ethical Review Board of the
Institute of Medical Science, the University of Tokyo
(IRB approval number 19-7).
Results
Medical backgrounds
Of the 607 patients who received home care at the 10
clinics, 346 (57%) had malignant diseases. Medical back-
grounds of the patients were shown in Table 1. Most
patients were in poor general conditions, and had sev-
eral complications other than malignant diseases.
Table 1 Patients’ medical backgrounds
Variables n
Age
<3 5y 3
35-50 y 9
51-60 y 33
61-70 y 69
71-80 y 108
81-90 y 86
>9 0y 3 8
Gender
Men/women 145/201
Performance status*
1/2/3/4/unknown 40/27/153/108/18
Types of malignant diseases
Lung cancer 80
Gastric cancer 47
Pancreatic cancer 17
Prostate cancer 16
Rectal cancer 16
Hematological malignancy 14
Cholangiocarcinoma 13
Liver cancer 12
Colorectal cancer 11
Breast cancer 10
Uterine cancer 10
Bladder cancer 9
Renal cancer 9
Ovarian cancer 8
Esophageal cancer 6
Gallbladder cancer 5
Laryngeal cancer 5
Renal pelvis cancer 5
Cancers of unknown origin 6
Others 47
Complications
Dementia 121
Cerebrovascular disease 24
Metastasis 135
Patients with two or more cancers 38
Cancer pain 81
Paralysis 48
*1: Performance status according to the Eastern Cooperative Oncology Group
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Social backgrounds of the patients were shown in Table
2. Of the 346 patients, 335 (97%) were economically
independent, and 336 (97%) lived with their families or
others.
Treatment at home
At the beginning of home care, neither the patients
themselves nor their families wished to receive any
aggressive cancer treatment. All the patients received
supportive treatments on the basis of the administration
of fluid replacement and oxygenation. Three received
intravenous hyperalimentation. Of 81 patients who com-
plained of cancer pain, 74 were given narcotic medica-
tions. Their adverse effects were controllable in these 74
patients.
Eleven patients received red cell transfusion at home.
There were no particular complications. No patients
received platelet transfusion.
Patients’ and their family members’ wish to die at home
At the beginning of home care, 143 patients (41%) and
174 family members (50%) expressed their wish to die
at home. Of the 143 patients, 122 (85%) were in agree-
ment with their families’ wishes. Right before death, 145
(41%) patients and 213 (62%) families expressed their
wish to die at home.
Four patients and seven families withdrew their
wish to die at home in the midcourse of home care.
For the patients, the reasons were an increased bur-
den on the family or caregivers (n = 3), and living
alone (n = 1). Meanwhile, for the family members,
the reasons were fear for sudden changes in the
patients’ conditions (n = 5) and an increased burden
on the family (n = 2).
Outcomes
The median duration of the home care was 47 days
(range, 0-2,712). The cumulative mortality during the
home care was shown in Figure 1.
224 patients died at home. For the remaining 122,
home care was terminated for reasons other than death.
They included hospitalization due to the complications
(n = 109), change of attending physicians (n = 8),
admission to a nursing home (n = 3), return to outpati-
ent treatment after improvement of the disease condi-
tion (n = 1), and disappearance (n = 1).
13 patients developed acute complications. 11 of them
were hospitalized after ambulance transportation, and
the home care was terminated. The two remaining
patients died at home.
Factors inhibiting the continuitation of home care
The results of a multivariate analysis were shown in
Table 3. The factors which inhibited the continuation of
home care were the non-use of home-visit nursing care
(hazard ratio [HR] = 1.78, 95% confidence interval [CI]:
1.05-3.00, p = 0.03), the fact that the patients themselves
do not wish to die at home (HR = 1.83, CI: 1.09-.3.07, p
= 0.02), women (HR = 1.81, CI: 1.11-2.94, p = 0.02), and
age (HR = 0.98, CI: 0.97-1.00, p = 0.02).
Discussion
This study revealed that medical backgrounds of cancer
patients receiving home care in Japan showed common
clinical features. For example, 322 (93%) of the patients
had solid cancers, and the majority of the cancer types
were lung (n = 80, 23%) and gastric cancer (n = 47,
14%). Our study reflects the situation in Japan, in a
similar way as previous studies conducted in other
countries [8]. Lung cancer is the primary cause of can-
cer death, and gastric cancer is in the second place in
Japan [9]. Meanwhile, patients with hematologic
Table 2 Social backgrounds of the patients and their
families
Variables n
Household type
Solitary 10
Elderly couple 32
Living with family, but solitary in daytime or nighttime 59
Others* 245
Residence
Own house 332
Others 14
Economic conditions
Independent 335
Receiving public assistance 8
Economic difficulties 3
* Some family members or caregivers lived together throughout the day.
Figure 1 Cumulative incidence of deaths during home care.X
axis indicates duration of home care (years).
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rence of sudden changes due to complications and need
f o ra d j u v a n tt h e r a p ys u c ha sb l o o dt r a n s f u s i o na n dp a l -
liative chemotherapy were probably the obstacles for
these patients [10].
Most patients were elderly, and had several complica-
tions. For example, 232 (67%) of the patients were 71
years old or older, 261 (75%) were PS 3-4, and 121
(34%) were complicated with dementia. The subjects in
this study were older than those in previous studies
reported from other countries [11,12]. These findings
suggest that even severely ill patients with poor general
conditions can be treated at home by providing ade-
quate care.
The therapeutic interventions conducted during home
care were mainly symptomatic treatments. In fact, all
the patients received supportive medications. Pain con-
trol is a major aim in patients with advanced cancer
[13]. In this study, 81 patients (23%) complained intense
pains. Among them, 74 were given narcotic medications
without serious complications. These findings were
comparable to previous studies [12]. Since most physi-
cians who provide home care are familiar with palliative
medicine, palliative treatment using narcotics can be
provided safely at home.
The majority of cancer patients who received home
care was financially independent, and did not receive
any public financial assistance. Such financial situations
were similar to those of previous studies [14,15]. Home
care might be an option limited to patients with suffi-
cient financial resources since it can increase the eco-
nomic burden on the patients. Meanwhile, 336 (97%)
received support from their families or from the staff of
the facility. Even patients who had lived alone and died
at home received nursing care by their families during
their last moments, suggesting that family or social sup-
ports are requisite for cancer patients to live their last
moments at their own homes.
This study showed that use of home-visit nursing care
services, will of the patients, their gender and age played
an important role in the continuation of home care. It is
reasonable to speculate that the use of home-visit nur-
sing care services contributes to the safe in home care
since medical providers visit more frequently and
patients are closely monitored. Women were found as a
significant factor for inhibiting the continuitation of
home care in this study while a previous study from
Taiwan showed that being female was an important
determinant of hospice home care [16]. In a meta-analy-
sis using studies mostly from the UK, the US, Australia,
and Canada, gender factor did not have significant effect
in dying at home [17]. Thus, differences of culture
among countries might influence the gender disparity.
In Japan, elderly care has been traditionally considered
as ‘women’sw o r k ’ [18] and national survey reported
that 69.4% of caregivers were women in 2010 [19]. An
explanation of the gender disparity might be that Japa-
nese women miss the opportunity to receive medical
home care in the background of traditional thinking of
gender role. Surprisingly, older age was associated with
longer continuation of home care. The exact reason
remains unknown; however, it is probable that cancer
might have been diagnosed by chance at an early stage
in elderly patients who had been treated at home for
other chronic diseases.
T h i ss t u d yp r o v i d e dv a l u a b l ei n f o r m a t i o no nh o m e
care for cancer patients; however, it still involves several
problematic issues. The most considerable problem is
that this was a small-scale retrospective study. For that
reason, it might be accompanied by a bias of which
researchers were unaware. For example, because this
study was conducted with physicians with a rich experi-
ence in home care, caution is required when generaliz-
ing these results. To overcome these problems,
validation by large-scale prospective studies should be
performed in the future.
Conclusions
This study revealed common clinical feature of cancer
home care in Japan: the majority of the population
received home care was elderly (67% of patients over 70
years of age), had poor performance status (75% patients
with PS 3-4) and had dementia (34%). Regarding social
background, 97% of cancer patients were economically
independent and lived with their families or others. Age,
gender, will and use of home-visit nursing care had
Table 3 Multivariate analysis on factors inhibiting the continuity of home care
Factors Tested variables Hazard ratio 95% confidence interval p value
Age Increasing age 0.98 0.97-1.00 0.02
Gender Women 1.81 1.11-2.94 0.02
Dementia Present 0.64 0.38-1.09 NS
Patient’s wish to die at home at the beginning of home care No wish 1.83 1.09-3.07 0.02
Residence Nursing home 2.98 0.86-10.25 NS
Visiting Nurse No use 1.78 1.05-3.00 0.03
NS: not significant.
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large, international cohort study to investigate the conti-
nuation of cancer home care should be considered since
this study has limitations such as nature of small sample
size and domestic study in Japan.
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